Kondapavulur Sravani, Cooke Daniel L, Kao Andrew, Amans Matthew R, Alexander Matthew, Darflinger Robert, Dowd Christopher F, Higashida Randall T, Damato Bertil, Halbach Van V, Matthay Katherine K, Hetts Steven W
1 Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.
2 Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.
Interv Neuroradiol. 2018 Apr;24(2):214-219. doi: 10.1177/1591019917749825. Epub 2018 Jan 17.
Background and purpose The purpose of this article is to estimate the distribution of superselective intra-arterial chemotherapy (IAC) delivery to ocular target tissue using quantitative digital subtraction angiography (qDSA). Materials and methods From March 2010 to January 2016, 50 ophthalmic artery contrast DSAs obtained immediately prior to IAC infusions in 22 patients were analyzed. This study was conducted under a retrospective review IRB (no. 10-01862). Parametric color-coded DSAs (iFlow, Siemens Medical) were post-processed (MATLAB, The Mathworks Inc.) using two methods: two box regions of interest (pre-retina and globe) and four custom regions of interest (ROIs-ophthalmic artery, choroid, supraclinoid internal carotid artery (ICA), cavernous ICA). Mean interobserver reliability of custom ROI selection is presented as a 95% confidence interval of interclass correlation, and fractional chemotherapy delivery to selected ROIs as means ± standard deviation in this study. Results The estimated fraction of chemotherapy delivered to the globe with the first method was 79.5%. Percentage regional delivery using the second method was as follows: ophthalmic artery, 85.8%; choroid, 60.5%; supraclinoid ICA, 14.2%. The cavernous ICA ROI (encompassing distal catheter and potential reflux) gave a signal equivalent to 9.3% of total delivery. Conclusion Parametric color-coded qDSA can estimate the fraction of IAC delivered to the retina and other orbital structures in ocular retinoblastoma patients. This information can inform delivery location and dosing strategies on a patient-specific basis.
背景与目的 本文旨在使用定量数字减影血管造影术(qDSA)评估超选择性动脉内化疗(IAC)在眼部靶组织中的分布情况。材料与方法 对2010年3月至2016年1月期间22例患者在IAC输注前立即获得的50次眼动脉造影DSA进行分析。本研究在回顾性审查机构审查委员会(编号10 - 01862)的批准下进行。使用两种方法对参数化彩色编码DSA(iFlow,西门子医疗)进行后处理(MATLAB,MathWorks公司):两个感兴趣区域框(视网膜前和眼球)以及四个自定义感兴趣区域(ROI - 眼动脉、脉络膜、海绵窦段颈内动脉(ICA)、海绵窦段ICA)。自定义ROI选择的观察者间平均可靠性以组内相关系数的95%置信区间表示,本研究中选定ROI的化疗分数以均值±标准差表示。结果 第一种方法估计输送到眼球的化疗分数为79.5%。第二种方法的区域输送百分比如下:眼动脉,85.8%;脉络膜,60.5%;海绵窦段ICA,14.2%。海绵窦段ICA ROI(包括远端导管和潜在反流)产生的信号相当于总输送量的9.3%。结论 参数化彩色编码qDSA可估计眼内视网膜母细胞瘤患者中IAC输送到视网膜和其他眼眶结构的分数。该信息可为基于患者个体的输送位置和给药策略提供依据。